Quarterly report · Q3
7446.TEDINET S100OW0Q
Period2021-10-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥27.9bn | 2021-10-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥36.2bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥27.2bn | 2020-10-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥763m | 2021-10-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥572m | 2020-10-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥814m | 2021-10-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥759m | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥608m | 2020-10-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥786m | 2021-10-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥612m | 2020-10-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥539m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥517m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥428m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥559m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥446m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥15.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥16.1bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥16.2bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.5bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥9.8bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.6bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.3bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.1bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥799m | at 2021-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥596.99 | 2021-10-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥185.03 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥564.91 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥467.38 | 2020-10-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥114.17 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 43.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.6% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.3% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2021-10-01 → 2022-06-30 | ¥318m |
| Otherother segments | revenue external | 2021-10-01 → 2022-06-30 | ¥318m |
| jpcrp040300-q3r_E02810-000Foodreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥2.4bn |
| jpcrp040300-q3r_E02810-000Foodreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥2.4bn |
| jpcrp040300-q3r_E02810-000Pharmaceutical Productsreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥13.8bn |
| jpcrp040300-q3r_E02810-000Pharmaceutical Productsreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥13.8bn |
| jpcrp040300-q3r_E02810-000Reagent For Clinical Testreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥11.4bn |
| jpcrp040300-q3r_E02810-000Reagent For Clinical Testreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥11.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-06-30 | ¥27.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-06-30 | ¥27.9bn |
| Otherother segments | revenue | 2020-10-01 → 2021-06-30 | ¥331m |
| Otherother segments | revenue external | 2020-10-01 → 2021-06-30 | ¥331m |
| jpcrp040300-q3r_E02810-000Foodreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥2.5bn |
| jpcrp040300-q3r_E02810-000Foodreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥2.5bn |
| jpcrp040300-q3r_E02810-000Pharmaceutical Productsreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q3r_E02810-000Pharmaceutical Productsreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q3r_E02810-000Reagent For Clinical Testreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥10.9bn |
| jpcrp040300-q3r_E02810-000Reagent For Clinical Testreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-10-01 → 2021-06-30 | ¥27.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-10-01 → 2021-06-30 | ¥27.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 381
| Item | Context | Value | Unit |
|---|---|---|---|
| Loss on sales of investment securities el | Prior1YTDDuration | 16000 | JPY |
| Loss on sales of investment securities el | CurrentYTDDuration | － | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | 21054000 | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | 29380000 | JPY |
| Other el | Prior1YTDDuration | 374000 | JPY |
| Other el | CurrentYTDDuration | － | JPY |
| Extraordinary loss | Prior1YTDDuration | 21527000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 29494000 | JPY |
| Income before income taxes | Prior1YTDDuration | 612046000 | JPY |
| Income before income taxes | CurrentYTDDuration | 786372000 | JPY |
| Income taxes current | Prior1YTDDuration | 152578000 | JPY |
| Income taxes current | CurrentYTDDuration | 212302000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 13663000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 15151000 | JPY |
| Income taxes | Prior1YTDDuration | 166241000 | JPY |
| Income taxes | CurrentYTDDuration | 227454000 | JPY |
| Profit loss | Prior1YTDDuration | 445805000 | JPY |
| Profit loss | CurrentYTDDuration | 558917000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 17863000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 19930000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 427941000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 538987000 | JPY |
| Profit loss | Prior1YTDDuration | 445805000 | JPY |
| Profit loss | CurrentYTDDuration | 558917000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 138298000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -186713000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 1292000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | 683000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 139591000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -186029000 | JPY |
| Comprehensive income | Prior1YTDDuration | 585396000 | JPY |
| Comprehensive income | CurrentYTDDuration | 372887000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 567486000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 353084000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 17910000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 19802000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02810-000PharmaceuticalProductsReportableSegmentsMember | 13441968000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02810-000ReagentForClinicalTestReportableSegmentsMember | 10907021000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02810-000FoodReportableSegmentsMember | 2523727000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OtherReportableSegmentsMember | 331286000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 27204004000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 27204004000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02810-000PharmaceuticalProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02810-000ReagentForClinicalTestReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02810-000FoodReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_OtherReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |